Organ regeneration technology shows promise for regenerating hair follicles
Kyocera Corporation has entered into a joint research project with Japan’s RIKEN national science institute and Organ Technologies, Inc. to develop a regenerative medical treatment for hair loss, with the goal of putting the technologies into practical use in 2020. The partnership aims to develop technologies and products for treating hair loss by regenerating hair follicles. Because no existing treatment can increase the number of hair follicles, any viable method of regenerating hair follicles has great potential to succeed where other methods fail.
As part of the joint research effort, Kyocera will lead technical aspects such as the development of cell processing devices. While various methods are under evaluation, Kyocera’s piezoelectric technology* is of particular interest as a means of discharging small amounts of viscid cells in a precise manner. This technology will be necessary to attach two types of stem cells collected from a patient and cultivated to create follicle cells for subsequent autografting in the same patient.
Kyocera is expanding on its expertise in creating medical components for orthopedic joint replacement and dental implants to support this future application of regenerative medicine.
Kyocera Corporation has entered into a joint research project with Japan’s RIKEN national science institute and Organ Technologies, Inc. to develop a regenerative medical treatment for hair loss, with the goal of putting the technologies into practical use in 2020. The partnership aims to develop technologies and products for treating hair loss by regenerating hair follicles. Because no existing treatment can increase the number of hair follicles, any viable method of regenerating hair follicles has great potential to succeed where other methods fail.
As part of the joint research effort, Kyocera will lead technical aspects such as the development of cell processing devices. While various methods are under evaluation, Kyocera’s piezoelectric technology* is of particular interest as a means of discharging small amounts of viscid cells in a precise manner. This technology will be necessary to attach two types of stem cells collected from a patient and cultivated to create follicle cells for subsequent autografting in the same patient.
Kyocera is expanding on its expertise in creating medical components for orthopedic joint replacement and dental implants to support this future application of regenerative medicine.
